77 min listen
Ep. 228: “Developing Regenerative Medicines” Featuring Dr. Stefan Irion
Ep. 228: “Developing Regenerative Medicines” Featuring Dr. Stefan Irion
ratings:
Length:
56 minutes
Released:
Oct 18, 2022
Format:
Podcast episode
Description
Dr. Stefan Irion is the Senior Vice President of Research at BlueRock Therapeutics, a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. He talks about the company's Parkinson's disease trial and the challenges of genetically manipulating stem cells. He also discusses his journey from physician to scientist and his personal connection to Parkinson's disease.
Released:
Oct 18, 2022
Format:
Podcast episode
Titles in the series (100)
Ep. 20: SCNT Featuring Dr. Dieter Egli: Guest Dr. Dieter Egli from the New York Stem Cell Foundation joins the hosts to talk about his work in using SCNT to derive new embryonic stem cell lines. They discuss his previous and current… by The Stem Cell Podcast